Innoviva (INVA) Assets (2010 - 2026)
Innoviva (INVA) reported Assets of $1.7 billion for Q2 2026, up 27.7% from $1.33 billion a year earlier but down 7.3% from the prior quarter.
Powered by 
Analysis
Innoviva (INVA) Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Innoviva posted Assets of $1.64 billion, up 25.7% from FY2024.
- Assets has increased for four consecutive years, with a five-year compound annual growth rate of 10.3% (FY2020 to FY2025).
- By year, Assets came in at $1.3 billion in FY2024 (+4.6%), $1.24 billion in FY2023 (+1.0%), $1.23 billion in FY2022 (+32.9%) and $926.4 million in FY2021 (-7.3%).
- Five-year quarterly Assets spans a low of $887.24 million in Q3 2021 and a high of $1.84 billion in Q1 2026.
- Year over year, Assets has now increased in each of the last five quarters, with growth averaging 18.3% over the last seven quarters.
- The high point for year-over-year Assets in five years was Q1 2026 (growth of 46.4%); the low point was Q4 2021 (a decline of 7.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.84 billion (Q1 2026), $1.64 billion (Q4 2025) and $1.43 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Innoviva | 1.54 Bn | -748.67 Mn | 90.62 Mn | 1.70 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.70 Bn |
| Mar 31, 2026 | 1.84 Bn |
| Dec 31, 2025 | 1.64 Bn |
| Sep 30, 2025 | 1.43 Bn |
| Jun 30, 2025 | 1.33 Bn |
| Mar 31, 2025 | 1.25 Bn |
| Dec 31, 2024 | 1.30 Bn |
| Sep 30, 2024 | 1.23 Bn |
| Jun 30, 2024 | 1.22 Bn |
| Mar 31, 2024 | 1.27 Bn |
| Dec 31, 2023 | 1.24 Bn |
| Sep 30, 2023 | 1.19 Bn |
| Jun 30, 2023 | 1.12 Bn |
| Mar 31, 2023 | 1.13 Bn |
| Dec 31, 2022 | 1.23 Bn |
| Sep 30, 2022 | 1.33 Bn |
| Jun 30, 2022 | 1.14 Bn |
| Mar 31, 2022 | 1.11 Bn |
| Dec 31, 2021 | 926.40 Mn |
| Sep 30, 2021 | 887.24 Mn |
API Access
Innoviva Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=INVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "INVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=INVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();